Sarasin & Partners LLP Boosts Stock Position in Colgate-Palmolive (NYSE:CL)

Sarasin & Partners LLP boosted its position in shares of Colgate-Palmolive (NYSE:CL) by 19.3% during the fourth quarter, Holdings Channel.com reports. The fund owned 3,537,856 shares of the company’s stock after acquiring an additional 571,131 shares during the quarter. Colgate-Palmolive accounts for 3.5% of Sarasin & Partners LLP’s investment portfolio, making the stock its 12th largest holding. Sarasin & Partners LLP’s holdings in Colgate-Palmolive were worth $321,626,000 at the end of the most recent reporting period.

Several other large investors have also added to or reduced their stakes in the company. XTX Topco Ltd bought a new stake in Colgate-Palmolive in the 2nd quarter valued at $423,000. Ieq Capital LLC raised its position in Colgate-Palmolive by 22.6% during the second quarter. Ieq Capital LLC now owns 38,617 shares of the company’s stock valued at $3,747,000 after purchasing an additional 7,130 shares during the period. AE Wealth Management LLC lifted its stake in shares of Colgate-Palmolive by 70.9% in the 2nd quarter. AE Wealth Management LLC now owns 22,607 shares of the company’s stock valued at $2,194,000 after purchasing an additional 9,382 shares during the last quarter. Sei Investments Co. lifted its position in Colgate-Palmolive by 1.8% in the second quarter. Sei Investments Co. now owns 609,139 shares of the company’s stock worth $59,111,000 after buying an additional 10,500 shares during the last quarter. Finally, Summit Trail Advisors LLC boosted its stake in Colgate-Palmolive by 2.6% during the second quarter. Summit Trail Advisors LLC now owns 5,490 shares of the company’s stock worth $533,000 after buying an additional 141 shares during the period. Hedge funds and other institutional investors own 80.41% of the company’s stock.

Colgate-Palmolive Trading Up 0.3 %

CL opened at $88.79 on Monday. Colgate-Palmolive has a 12 month low of $79.69 and a 12 month high of $109.30. The stock has a fifty day moving average price of $92.20 and a 200-day moving average price of $97.75. The firm has a market cap of $72.55 billion, a price-to-earnings ratio of 25.44, a PEG ratio of 3.01 and a beta of 0.44. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46.

Colgate-Palmolive Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be issued a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.25%. The ex-dividend date is Tuesday, January 21st. Colgate-Palmolive’s dividend payout ratio is currently 57.31%.

Analyst Upgrades and Downgrades

CL has been the topic of several recent analyst reports. Wells Fargo & Company reduced their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a research note on Tuesday, January 7th. Piper Sandler decreased their price objective on shares of Colgate-Palmolive from $121.00 to $112.00 and set an “overweight” rating for the company in a research note on Monday, January 6th. JPMorgan Chase & Co. cut their target price on Colgate-Palmolive from $109.00 to $103.00 and set an “overweight” rating on the stock in a research note on Thursday. StockNews.com lowered Colgate-Palmolive from a “buy” rating to a “hold” rating in a research note on Thursday, January 9th. Finally, Barclays cut their price objective on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a research report on Friday. One analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $101.11.

Insider Buying and Selling at Colgate-Palmolive

In other news, CFO Stanley J. Sutula III sold 45,410 shares of the business’s stock in a transaction on Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at $3,456,283.86. The trade was a 55.29 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.34% of the stock is owned by insiders.

Colgate-Palmolive Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.